Close
Close

Genelux Corporation - Advanced Stage Cancer (Solid Tumor Disease for 4 Patients)

Partner

Not provided

Rare Disease

Advanced Stage Cancer (Solid Tumor Disease for 4 Patients)

Sponsor

Genelux Corporation

Access Program Information

GL-ONC1 expanded access is for patients who are ineligible for an ongoing GL-ONC1 clinical trial. Expanded access is intended to treat individual patients with advanced stage cancers, including blood cancer, with no standard of care options for treatment. Potential patients will be evaluated individually depending on GL-ONC1 product supply.

Contact

Contact: Susan Coakley (407-303-2090)

Locations
  • United States
  • Orlando, Florida, United States

Free Newsletter